Clinical trial
Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial
NCT00133822 · Emory University, Other · Completed
Key facts
| NCT number | NCT00133822 |
|---|---|
| Title | Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial |
| Official title | Placebo-Controlled Trial of Risperidone Augmentation for SSRI-Resistant Civilian PTSD |
| Lead sponsor | Emory University, Other |
| Collaborators | Janssen, LP Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Post-Traumatic Stress Disorders |
| Intervention type | Drug |
| Interventions | Sertraline and Risperidone |
| Enrollment | 65 |
| Start date | Apr 1, 2004 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Aug 24, 2005 |
| Last update posted | Aug 19, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: